|
RSU1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91480999999216E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.04350000005049E-06 |
| Normal-vs-Stage2 |
5.801800E-02 |
| Normal-vs-Stage3 |
4.996000E-03 |
| Normal-vs-Stage4 |
1.327500E-02 |
| Stage1-vs-Stage2 |
3.962600E-01 |
| Stage1-vs-Stage3 |
3.779600E-01 |
| Stage1-vs-Stage4 |
2.705000E-01 |
| Stage2-vs-Stage3 |
8.715800E-01 |
| Stage2-vs-Stage4 |
9.609000E-01 |
| Stage3-vs-Stage4 |
7.977200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.88030000000972E-06 |
| Normal-vs-AfricanAmerican |
5.748000E-02 |
| Normal-vs-Asian |
8.981200E-01 |
| Caucasian-vs-AfricanAmerican |
5.078600E-01 |
| Caucasian-vs-Asian |
2.952600E-01 |
| AfricanAmerican-vs-Asian |
4.815600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.91989999999543E-05 |
| Normal-vs-Female |
2.164900E-04 |
| Male-vs-Female |
9.432800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.161300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.18149999999806E-05 |
| Normal-vs-Age(61-80Yrs) |
1.458140E-03 |
| Normal-vs-Age(81-100Yrs) |
1.790360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.297000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.711800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.227200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.896630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.296800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.505000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.121800E-03 |
| Normal-vs-Grade 2 |
7.32690000004865E-07 |
| Normal-vs-Grade 3 |
2.395200E-03 |
| Normal-vs-Grade 4 |
6.498400E-02 |
| Grade 1-vs-Grade 2 |
4.802200E-02 |
| Grade 1-vs-Grade 3 |
4.733800E-02 |
| Grade 1-vs-Grade 4 |
5.616300E-03 |
| Grade 2-vs-Grade 3 |
3.216200E-02 |
| Grade 2-vs-Grade 4 |
5.541900E-02 |
| Grade 3-vs-Grade 4 |
6.478200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.20949999962805E-07 |
| Normal-vs-ccB subtype |
7.123800E-03 |
| ccA subtype-vs-ccB subtype |
5.111800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.185700E-04 |
| Normal-vs-N1 |
1.066600E-01 |
| N0-vs-N1 |
6.036200E-01 |
|
|
